USE OF A COMBINATION OF TETRAHYDROBIOPTERINS AND LYMPHOKINES FOR THE MANUFACTURE OF A MEDICAMENT POSSESSING AN ENHANCED IN VIVO AND IN VITRO LYMPHOKINE ACTIVITY

摘要

The use of pterins to increase the activity of lymphokines and other cell growth factors, and a diagnostic or theraupeutic preparation that contains pterins combined with lymphokines. Adding pterins to lymphokines can increase the activity of the lymphokines by 3 to 5 times.